Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 79, pseudogene" (RNU6-79P) is a **processed pseudogene** derived from the U6 small nuclear RNA (snRNA) gene family. U6 snRNA is an essential structural and catalytic RNA component of the major spliceosome, a ribonucleoprotein complex critical for the splicing of pre-mRNA in the nucleus of eukaryotic cells[3][2]. However, RNU6-79P itself does **not produce a functional RNA or protein** and does *not participate in splicing or any known regulatory pathway*. Pseudogenes like RNU6-79P arise by retrotransposition events and do not encode for biologically active molecules[5][1]. There is no evidence that RNU6-79P has a role in disease, is a therapeutic target, or is druggable; its status is that of a genomic marker for retrotransposition dynamics. There are no described disease-associations, mechanisms of action, biomarkers, or pharmacological safety concerns for this pseudogene. **Note:** - RNU6-79P is a pseudogene, not a coding gene, protein, or therapeutic target. - The correct target for biological function and therapeutic utility is U6 small nuclear RNA (snRNA), not this pseudogene. - Its utility is limited to genomics research, especially for studying retrotransposition and pseudogene formation in the human genome[5][1]. - No aliases besides standardized gene symbols are in common use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 79, pseudogene (RNU6-79P).